Urinary BTA: indicator of bladder cancer or of hematuria (Q36509699)

14 August 2017

Urinary BTA: indicator of bladder cancer or of hematuria (English)

1 reference

14 August 2017

1 reference

Makito Miyake

1

1 reference

14 August 2017

Steve Goodison

2

1 reference

14 August 2017

Wasia Rizwani

3

1 reference

14 August 2017

Shanti Ross

4

1 reference

14 August 2017

H Bart Grossman

5

1 reference

14 August 2017

Charles J Rosser

6

1 reference

14 August 2017

30 August 2012

1 reference

14 August 2017

World Journal of Urology

1 reference

14 August 2017

30

1 reference

14 August 2017

6

1 reference

14 August 2017

869-873

1 reference

Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537326

Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537326

Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537326

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537326

Complement factor H or a related protein is a marker for transitional cell cancer of the bladder.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537326

Clinical evaluation of the BTA trak assay and comparison to voided urine cytology and the bard BTA test in patients with recurrent bladder tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3537326

Estimation of the Youden Index and its associated cutoff point

30 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00345-012-0935-9

Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer?

21 January 2018

1 reference

12 December 2020

Re: The BTA stat test is nonspecific for hematuria: an experimental hematuria model

1 reference

12 December 2020

Comparative analysis of sensitivity to blood in the urine for urine-based point-of-care assays (UBC rapid, NMP22 BladderChek and BTA-stat) in primary diagnosis of bladder carcinoma. Interference of blood on the results of urine-based POC tests

1 reference

12 December 2020

The BTA stat test is nonspecific for hematuria: an experimental hematuria model

1 reference

12 December 2020

Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer

1 reference

12 December 2020

Quantitative detection of human complement factor H-related protein in transitional cell carcinoma of the urinary bladder

1 reference

12 December 2020

10.1007/S00345-012-0935-9

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22932760

1 reference